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Steve Burden* and Yosef Yarden² domains. Likewise, the single ligand is synthesized as
a transmembrane precursor containing a characteristic*Molecular Neurobiology Program
Skirball Institute epidermal growth factor (EGF) -like motif with six cyste-
ine residues arranged in three loops (reviewed by Korn-New York University Medical Center
New York, New York 10016 feld, 1997). The Drosophila relative of ErbB (DER), how-
ever, binds four different ligands, one of which, vein,²Department of Molecular Cell Biology
The Weizmann Institute of Science has no transmembrane precursor, but like certain NRG
isoforms, carries an immunoglobulin (Ig) -like motif. An-Rehovot 76100
Israel other ligand, argos, is an antagonist (reviewed by Perri-
mon and Perkins, 1997). A mammalian antagonist has
yet to be identified. Like their mammalian counterparts,There has been rapid growth in our understanding of
the invertebrate ErbB receptors also signal primarilyneuregulins (NRGs), a large group of structurally related
through the Ras-Raf-MAP-kinase pathway. In both in-polypeptide factors, and their receptors, four transmem-
vertebrates and mammals, the signaling module is nec-brane tyrosine kinases of the ErbB family. This new
essary for development of multiple and seemingly unre-knowledge reveals a complex signaling system, used in
lated cell lineages and organs, and its requirementdifferent tissues to regulate cell survival, proliferation,
coincides with more than one developmental phase.and differentiation. Only 5 years ago, independent ef-
Another lesson that is mirrored in mammals is the tightlyforts to identify activities responsible for stimulating
controlled availability of the ligands, whose range ofNeu/ErbB-2 phosphorylation, Schwann cell proliferation,
action is relatively short; the synthesizing cell and theand acetylcholine receptor synthesis resulted in the
responsive tissue are juxtaposed or only a few cell layersstriking discovery that the peptide factors, Neu differen-
apart.tiation factor (NDF/heregulin), glial growth factor (GGF),
and acetylcholine receptor inducing activity (ARIA) were
the products of the same gene. The name neuregulin, The ErbB Signaling Network of Mammals
originally introduced by Mark Marchionni, represents Over the last 800 million years, the ErbB-NRG module
a composite of the initial names and recognizes the has undergone remarkable expansion through gene du-
importance of these factors in the nervous system. In- plication events to reach its present state of four recep-
tensive efforts have now clarified not only an enormous tors and a few dozen ligands. It is likely that this expan-
functional diversity of the NRG-ErbB signaling network, sion reflects an increasing physiological demand for
but also its role in midgestation organogenesis as a key control of additional cell lineages. The diversification
determinant in differentiation of several cell lineages potential of the module is enhanced by combinatorial
(Figure 1). Instructive illustrations of this diversity were protein±protein interactions. The diversity of responses
provided by presentations at a recent workshop orga- is generated by three levels of interacting molecules:
nized in the Banbury Center at the Cold Spring Harbor first, there are multiple ligands whose receptor-binding
Laboratory by Mark A. Marchionni (Cambridge Neuro- motifs, an EGF-like domain, are flanked by variable do-
Science) and Greg Lemke (Salk Institute, La Jolla, CA) mains. Second, all ligands bind to a set of receptors
on ªNeuregulins and Neuregulin Receptors.º that can generate all possible homo- and heterodimers.
Neuregulins (NRGs) and their receptors are evolution- Third, each different receptor dimer can couple to a
arily conserved in both structure and function and were distinct set of cytoplasmic signaling proteins.
present more than a billion years ago. Therefore, we Ligands
start this review with lessons learned from invertebrates. A newly isolated family of NRG-like ligands, termed
We then discuss the structural basis of signaling by NRG2, was described by three groups at the workshop
these ligands and their receptors, including a newly (H. Chang, Stanford University, Palo Alto, CA; C. Lai,
discovered second NRG gene, and review current Scripps Institute, La Jolla, CA; and A. Goodearl, Millen-
thoughts on how diversity is generated through combi- nium Pharmaceuticals, Boston). Like NRG isoforms,
natorial protein interactions. Individual organs and cell these ligands come in several variants, which probably
lineages, whose development is critically regulated by arose via alternative splicing from a gene on chromo-
NRGs, are then described in light of recent gene tar- some 5, which is distinct from the human NRG gene
geting, by in vivo and in vitro experiments. (located on chromosome 8 and now termed NRG1). The
structure of these new ligands includes an EGF-like
motif, which has two variants, a and b, as well as aInvertebrate ErbB Signaling Modules
The simplest version of the NRG-ErbB network is found collection of other recognizable extracellular motifs that
are variably present: a signal peptide, two variants of ain C. elegans; it is comprised of a single receptor, the
product of the let-23 gene, and a single ligand encoded cysteine-containing N-terminal domain, either a cyste-
ine-rich domain (CRD) or a domain distantly related toby lin-3. Nevertheless, the major structural determinants
of mammalian NRGs and ErbBs are already present: the a kringle motif, an Ig-like loop, a glycosylation domain,
and a transmembrane domain. The presence or absencereceptor's ectodomain is a duplicated structure carrying
two cysteine-rich blocks, and its cytoplasmic portion of the latter domain determines whether the precursor
is made as a transmembrane protein or as a secretedis a tyrosine kinase flanked by noncatalytic regulatory
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Figure 1. Physiological Functions of the NRG-ErbB Signaling Module
The center panel schematically shows the four ErbB proteins crossing the plasma membrane (horizontal bar). ErbB-3 and ErbB-4 are the
direct NRG receptors, whereas ErbB-1 and ErbB-2 function as coreceptors. The tyrosine kinase domain of ErbB-3 is inactive (crossed). The
color code of the receptors is maintained in the other panels, each presenting one of the known roles of NRGs (functions symbolized by thick
arrows). Note juxtaposition of the sources of NRG (blue) and the responsive cells (red). AChR, acetylcholine receptor; SC, Schwann cell; and
NRG, neuregulin.
polypeptide. According to a new nomenclature, the vari- Thus, the transmembrane precursor forms of NRGs may
also function independently of ErbB proteins.ous isoforms are grouped into three types: type I in-
cludes variants with an Ig loop and a glycosylation do- Both NRG1 and NRG2 isoformsbind directly to ErbB-3
and to ErbB-4, but they recruit ErbB-1 and ErbB-2 asmain (e.g., isoforms originally named NDF and ARIA);
NRGs with an Ig loop but no glycosylation domain are coreceptors. Whereas ErbB-2 has no known direct li-
gand, ErbB-1 binds six mammalian EGF-like molecules:termed type II (e.g., the NRG isoform originally called
GGF-II); and the CRD domain-containing factors, which EGF, transforming growth factor a, heparin-binding
EGF-like growth factor (HB-EGF), amphiregulin, epi-were originally named sensory and motor neuron±
derived factor (SMDF; Ho et al., 1995), are now termed regulin, and betacellulin. The latter, along with HB-EGF
(Elenius et al., 1997) and possibly additional ligands,type III NRGs. The cytoplasmic tails of some proNRG
isoforms are longer than some of the extracellular por- also binds to ErbB-4 (D. Stern, Yale University, New
Haven, CT). The exact role of the structural heterogene-tions, and their lengths are variable. They may function
in ªreverse signalingº since the region common to all ity of NRGs is still unknown. Best understood is the
variation in the EGF-like receptor-binding domain. Thetransmembrane NRG1s appears to associate specifi-
cally with certain cytoplasmic signaling proteins (D. C-terminal loop of NRG1 determines the strength of
receptor binding and has a role in determining whichFalls, Emory University, Atlanta). Further, the transmem-
brane isoform proNRG1-b2 has recently been isolated in receptor heterodimers will form: the higher affinity b
isoform stabilizes both ErbB-3/ErbB-2 and ErbB-3/a screen for apoptosis-inducing genes, but its function is
apparently cell autonomous (Grimm and Leder, 1997). ErbB-1 heterodimers, whereas the a isoform recruits
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only the former complex (Pinkas-Kramarski et al., 1996). is a dimer interface, and therefore may act as a dimeriza-
tion site (Stern).In addition, each NRG isoform has a distinct spatial
and temporal pattern of expression (C. Birchmeier, Max According to an alternative model (Y. Yarden, Weiz-
mann Institute, Rehovot, Israel), NRGs are bivalentDelbruÈ ck Center, Berlin; N. Ratner, University of Cincin-
nati). For example, type I isoforms, which are the only ligands; they first bind a direct receptor (either ErbB-3
or ErbB-4) through an N-terminally located high affinityNRG1 isoforms detectable at early embryonic ages, are
the predominant species expressed in the endocardium, site, and then a second site of NRG, whose affinity is
lower and specificity broader, selects a coreceptor withwhile type II NRGs are the major isoforms expressed in
embryonic skeletal muscle, and type III NRGs are pres- some preference for ErbB-2. High resolution NMR stud-
ies (Jacobsen et al., 1996) and application of phageent in sympathetic, motor, and sensory neurons (X. Yang
and L. Role, Columbia University, New York). On the display technology to NRG (Sliwkowski) indirectly sup-
port the existence of two receptor contact sites. His2other hand, all NRG1 types are expressed in the ventric-
ular zone of the telencephalon. In addition, stromal cells (178) and Leu3, two invariant residues located at the
N-terminus of the EGF-like domain, are essential forunderlying many epithelial cell layers of parenchymal
organs are a rich source of certain NRGs. NRG binding to ErbB-3 (see also Barbacci et al., 1995),
whereas several C-terminal residues dictate binding toReceptors
The two direct NRG receptors, ErbB-3 and ErbB-4, and both ErbB-3 and ErbB-4. Consistent with bivalency of
another ErbB ligand, EGF, recent biophysical measure-their two coreceptors, ErbB-1 and ErbB-2, qualify as
distinct components of a signaling network in that they ments determined several possible EGF:ErbB-1 stoi-
chiometries in solution, of which the 2:2 complex pre-differ in most functional aspects, yet are capable of
extensive intermolecular interactions. In addition to li- dominates (Lemmon et al., 1997). In addition, affinity
labeling with EGF indicates that the C-terminus of thisgand specificity and affinity, expression patterns, and
intracellular trafficking following ligand binding, the four ligand contacts the receptor's N-terminus, whereas the
C-tail of EGF is juxtaposed to the sequence interveningNRG receptors differ in kinase activity and substrate
selectivity. Most remarkable is ErbB-3, whose catalytic the two cysteine-rich domains of ErbB-1 (Summerfield
et al., 1996). Thus, NRGsmay drive receptordimerizationfunction and endocytosis are both impaired by compari-
son to the other three receptors (Baulida et al., 1996). through a mechanism that combines conformational al-
terations in receptors with bivalent ligand interactionsThe deficiency in catalytic function, however, can be
overcome by the process of ligand-induced receptor generating a series of molecular complexes, including
a stable quaternary complex of two ligands bridging twodimerization, an essential step that precedes receptor
phosphorylation and intracellular signaling. Although receptors. Presumably, each NRG isoform is character-
ized by a unique combination of the two sites, therebyErbB-3 homodimers are functionally defective, this re-
ceptor is recruited into heterodimers by the three other favoring certain receptor combinations.
Effector Signaling PathwaysErbB proteins. Thus, ErbB-3 signaling depends not only
on NRG binding, but also requires association with other As is the case for other receptor tyrosine kinases, ligand-
induced autophosphorylation of ErbB proteins on spe-ErbB proteins. Ligand-induced formation of homo- and
heterodimers is shared by the other ErbB proteins, and cific tyrosine residues establishes dockingsites for cyto-
plasmic signaling proteins sharing a phosphotyrosineall 10 possible receptor combinations can exist, includ-
ing a homodimer of the ligand-less ErbB-2, which is binding motif (SH2 or PTB domains). Due to differences
in the amino acid sequences surrounding phosphorylationformed as a consequence of either overexpression or an
oncogenic mutation within the transmembrane domain. sites of each receptor, different sets of signaling pro-
teins become associated with each of the 10 possibleSelection of a coreceptor by a ligand-occupied direct
receptor is clearly a nonrandom process that follows ErbB complexes. Several substrates, like Grb-2 and Shc,
are shared by most ErbB species. However, others likehierarchical rules. For example, ErbB-2-containing het-
erodimers are preferred, and heterodimers that can be the negative regulator c-Cbl (Levkowitz et al., 1996) and
the phosphatidylinositol-specific phospholipase (PLCg),driven by two types of ligands (e.g., ErbB-1/ErbB-3 com-
plexes) are better stabilized by NRG than by EGF (Tzahar are recruited only to ErbB-1, and possibly ErbB-2 (Co-
hen et al., 1996), resulting in calcium mobilization onlyet al., 1996). How ligand binding promotes different re-
ceptor combinations is currently an open question. Li- in response to EGF.
ErbB specificity of other substrates, such as Src andgand affinities of the various dimer combinations differ
significantly, even when dimers are artificially stabilized PI-3 kinase, must still be examined in cells whose reper-
toire of these receptors is genetically manipulated.with immunoglobulin Fc tails (ErbB-IgG; M. Sliwkowski,
Genentech). This is exemplified by heterodimeric com- Nevertheless, analyses of several cellular systems ex-
pressing individual, or pairs of, ErbB proteins have alreadyplexes of ErbB-3 or ErbB-4 with ErbB-2, whose affinities
for NRGs exceed those of other combinations, including reached a consensus on the complementarity of various
pairs (Riese et al., 1995; Cohen et al., 1996; Pinkas-an ErbB-3/ErbB-4 heterodimer. Studying the ErbB-2/
ErbB-3 heterodimer with an anti-ErbB-3 monoclonal an- Kramarski et al., 1996; Tzahar et al., 1996; Zhang et al.,
1996). Homodimers are in general less active than hetero-tibody and the corresponding ErbB-IgG, Sliwkowski
supported the possibility that a conformational alter- dimers in stimulating cell proliferation, and ErbB-2-con-
taining heterodimers are superior to other heterodimerication takes place after NRG binding, exposing a cryptic
dimerization site that recruits ErbB-2. Replacements of complexes. The least effective and most unstable dimer
appears to be the NRG-driven ErbB-3/ErbB-4 complex,specific residues of ErbB-2 with a cysteine indicate that
the juxtamembrane portion of the extracellular domain and dimers formed between ErbB-1 and either NRG
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receptor display an intermediate signaling potency. The heterodimers of NRG receptors. Apparently, by requir-
ing heterodimers, cardiac development gains an addi-remarkable mitogenic superiority of the ligand-less pro-
tein, ErbB-2, attracted significant attention because this tional control level: the availability of a coreceptor. As
for other growth factors, a clinical connection is in sight.protein was implicated, more than other members of the
family, in cancer development. Functional inactivation of Since expression levels of NRG, ErbB-2, and ErbB-3
increase following treatments that induce cardiac hyper-ErbB-2 demonstrated that ErbB-2 amplifies and pro-
longs signaling by NRG and EGF through deceleration trophy, an adaptive or pathological thickening of the
heart's wall, the possibility that this hypertrophy mayof the rate of ligand dissociation (Graus-Porta et al.,
1995; Karunagaran et al., 1996). Presumably, complexes be stimulated by increased NRG/ErbB signaling was
raised by K.-F. Lee.containing a ligand bound to a direct receptor and ErbB-2
as a coreceptor are long-lived due to retarded ligand
dissociation and a relatively slow rate of ErbB-2 endocy-
NRGs in Schwann Cell andtosis. On the other hand, because ErbB-2 is a strong
Oligodendrocyte Differentiationactivator of the MAP-kinase pathway, its heterodimers
Most myelin-forming cells of the peripheral nervous sys-are most potent in signaling.
tem develop from the neural crest in a multistep process
requiring contact with neurons. NRGs are importantNRGs in Cardiac Development
neuron-derived factors, which control Schwann cell dif-Quite unexpectedly, but in agreement with the notion
ferentiation, and are likely to have a critical role in regu-that NRGs act through a signaling network rather than
lating Schwann cell number. In this case, a heterodimervia a direct receptor, targeting of the genes encoding
of ErbB-2 with ErbB-3, rather than with ErbB-4, is theNRG (C. Birchmeier), ErbB-2 (K.-F. Lee, Salk Institute),
active receptor (Levi et al., 1995; Grinspan et al., 1996).and ErbB-4 (M. Gassman, Salk Institute) inmice resulted
In fact, ErbB-2 involvement in proliferation of Schwannin an almost identical cardiac malformation (Gassmann
cells was inferred long ago on the basis of Schwannomaet al., 1995; Lee et al., 1995; Meyer and Birchmeier,
induction by an oncogenic mutant of the rodent ErbB-2.1995; Kramer et al., 1996). Homozygous embryos die in
In cell culture, NRGs are the only factors able to mimicutero at around embryonic day 10, presumably due to
neurites in supporting survival of Schwann cell precur-defects resulting from the absence of heart trabeculae,
sors, and a soluble ErbB-4 can block neuronal supportthe finger-like extensions of the heart's wall. The only
(K. Jessen, University College, London). The precursorsprevious clue for involvement of NRGs in cardiac devel-
first appear around embryonic day 12.5 in the mouse,opment was derived from expression studies that local-
and by embryonic day 15, they complete differentiationized NRGto theendothelial cells of the endocardium and
to Schwann cells expressing the calcium binding proteinboth ErbB-2 and ErbB-4 to the adjacent heart muscle of
S100 and the transcription factor Krox-20 (Murphy et al.,the ventricular wall, the myocardium. In the absence of
1996). The latter, along with the cyclic-AMP responsiveany of the three components, the inductive effect of the
element binding protein (CREB), is activated by NRG inendocardium on the myocardium is defective: the wall
Schwann cells. Consistent with the role of NRG in precur-does not protrude into the chamber to form the trabecu-
sor survival, mice lacking NRG expression displayed se-lae. Interestingly, inactivation of NRG in chick embryos,
verely reduced numbersof presumptive Schwann cell pre-using a novel ribozyme-based antisense strategy,
cursors along trunk projections of nerves that normallyresulted in trabeculation defects similar to those ob-
express NRG and become ensheathed by Schwann cells.served inmice (Lemke). The short-range inductive action
Unlike mice that are homozygous for the EGF-like do-of NRG in mammalian heart development absolutely
main of NRG (NRGEGF2/2), mice that are homozygousdepends on the presence of both the receptor, ErbB-4,
mutant in the Ig-like domain (NRGIg2/2) but express otherand the coreceptor, ErbB-2. Thus, contrary to in vitro
NRG isoforms, contain Schwann cells along axonal pro-studies implying that ErbB-4 can transmit signals in the
jections of cranial nerves (C. Birchmeier). These resultsabsence of ErbB-2, homodimers of ErbB-4 are inactive
indicate that Schwann cells do not depend on the Ig-in ventricle differentiation.
like isoform of NRG. Since the most abundant NRG iso-The other direct NRG receptor, ErbB-3, is not involved
form in motor and sensory neurons, CRD-NRG, lacksin trabeculation as its expression is restricted to the
the Ig domain, but instead has a CRD (Yang and Role),mesenchyme of the endocardial cushion, which devel-
it seems likely that isoforms containing the CRD areops into valves. Indeed, the hearts of ErbB-32/2 mice
sufficient to initiate Schwann cell differentiation. Inter-display delayed but otherwise normal trabeculation, but
estingly, Schwann cells are present in trigeminal andtheir atrioventricular valves are rudimentaryand thinned,
dorsal root ganglia of ErbB-32/2 animals (E13.5), butleading to death in utero at E13.5 (S. Erickson, Genen-
their numbers are reduced in both the ganglia and theirtech). As the ErbB-3-defective mice survive longer than
nerve projections (Erickson). In addition, sciatic nervesthe other mutants, many additional sites of NRG-ErbB-3
from adult ErbB-31/2 mice displayed reduced conduc-functions were observed in these embryos (see below).
tion velocity, in agreement with a Schwann cell defect.The endocardium-derived NRG mediates formation of
On maturation, Schwann cells respond to NRGs bycushion mesenchyme, from which valve primordia evolve.
enhanced proliferation, probably reflecting the ability ofThe identity of the ErbB-3 coreceptor in valvuloseptal
axons to maintain an appropriate ratio tomyelin-formingdifferentiation is unknown, as neither ErbB-1 nor ErbB-2
Schwann cells (Syroid et al., 1996). Although matureare expressed in the cushion. Thus, two different as-
Schwann cells synthesize certain transmembrane iso-pects of cardiac development, trabeculation and valvu-
loseptal formation, are critically regulated by distinct forms of NRG and display constitutive phosphorylation
Meeting Review
851
of ErbB-3 (Rosenbaum et al., 1997), factor concentration during the disease reduced the frequency of clinical
relapses. The mechanism of action is unclear; indeed,may not be sufficiently high to maintain proliferation via
an autocrine mechanism (Ratner), indicating that other it is possible that NRG acts indirectly on immune cells
rather than directly on oligodendrocytes. Nevertheless,factors may have a role in regulating postnatal cells.
Nevertheless, NRG at low concentrations increases di- NRG clearly enhanced the extent of myelination in these
mice, suggesting the need for further study of a potentialrected migration of Schwann cells cultured in vitro on
peripheral nerves (Mahanthappa et al., 1996). therapeutic role for NRG in multiple sclerosis.
An interesting interplay between NRG and sonicNRG expression and NRG-mediated signaling change
following nerve injury. Wallerian degeneration of the sci- hedgehog (Shh) is emerging from studies of oligoden-
drocyte development in the chick spinal cord (R.H.atic nerve causes Schwann cells to up-regulate expres-
sion of certain NRG isoforms, along with ErbB-3 and Miller, Case Western Reserve University, Cleveland).
Since oligodendrocyte precursors are located in theErbB-2 (Carroll et al., 1997). Because these Schwann
cells are more intensely stained with antibodies specific ventral neural tube, oligodendrocytes do not develop in
explants of the dorsal portion of the tube. Although nei-for a major tyrosine autophosphorylation site in ErbB-2
(C.D. Stiles, Dana Farber Cancer Institute, Boston), ther NRG nor low concentrations of Shh could induce
oligodendrocytes in explants of dorsal neural tube, thenerve degeneration is apparently accompanied by in-
creased NRG signaling. Schwann cells at the neuromus- two ligands together collaborated to induce oligoden-
drocyte differentiation in these explants.cular synapse provide another example for a trophic
neural effect, as will be discussed below.
Like Schwann cells, differentiation of oligodendro-
NRGs in the Neuromuscular Synapsecytes, the myelin-forming cells of the central nervous
NRGs play an important role at neuromuscular syn-system, is profoundly influenced by neurons. While mi-
apses, where they are thought to act as a signal thatgrating from the subventricular zone to tracts of the white
stimulates transcription of certain genes, includingmatter, the progenitor cell progressively assumes a ma-
those encoding acetylcholine receptor (AChR) subunits,ture oligodendrocyte phenotype. J. Salzer (New York
in nuclei near the synaptic site. The first in vivo evidenceUniversity) reported that NRG is mitogenic to both cell
supporting this notion was presented by G. Fischbachtypes in vitro. Moreover, NRG reverses differentiation of
(Harvard Medical School), who reported that mice thatmyelin-forming oligodendrocytes, and under certain in
are heterozygous for the Ig allele of NRG (NRGIg1/2) arevitro conditions, it can inhibit commitment to bothan oligo-
mildly myasthenic. These heterozygous mice have fewerdendrocyte lineage (at the pro-oligodendrocyte stage) and
(50%) AChRs at their neuromuscular synapses, support-to type 2 astrocytes. Strikingly, NRG similarly inhibits
ing the idea that NRG has a role in stimulating AChRexpression of myelin-specific proteins by Schwann cells
synthesis in synaptic nuclei, and that the concentration(A. Mudge, University College, London; Cheng and
of NRG at the synapse is limiting. The mutant miceMudge, 1996). While these activities should be verified
apparently compensate for the deficit in AChR numberin vivo, they suggest that NRG has a common role in
by releasing more acetylcholine from their nerve termi-the myelinating cells of both the central and peripheral
nals, measured as an increase in quantal content, andnervous systems. It enables neurons to enlarge the pool
this result may explain why the heterozygous mice areof premyelinating glial cells, and only after NRG-ErbB
behaviorally normal. Nevertheless, tetanic stimulationsignaling has been attenuated can myelination proceed.
of their motor nerves in vitro showed that synaptic trans-Indeed, studies presented by J. Grinspan and S. Scherer
mission fails more readily in NRGIg1/2 mice, further indi-(University of Pennsylvania, Philadelphia) indicate that
cating that NRG has a role in neuromuscular function.the pool of premyelinated Schwann cells is the one regu-
The Ig isoform of NRG is not the major NRG isoformlated by axonal NRG during early postnatal develop-
in motor neurons, and indeed the spinal cord of NRGIg1/2ment. After axotomy, which removes the source of axonal
mice have nearly normal levels of NRG. Since the Ig-NRG, they observed enhanced apoptosis of premy-
like domain is crucial for binding to heparan sulfate pro-elinating Schwann cells, and the increase in apoptosis
teoglycans, it may promote accumulation of this isoformwas completely prevented by the application of exoge-
in the extracellular matrix of the synaptic cleft, evennous NRG (Grinspan et al., 1996). Similar rescue of
during stages of development in which the abundanceSchwann cells was observed at neuromuscular junc-
of this mRNA is relatively low (Fischbach). An alternativetions, Golgi tendon organs, and Pacinian corpuscle (W.
explanation for the apparent paradox of reduced neuro-Thompson, University of Texas, Austin).
muscular function in mice containing nearly normal lev-The interaction of NRG with myelinating cells has im-
els of NRG in their spinal cord was raised by S. Burdenplications for demyelinating disorders of the nervous
(Skirball Institute, New York). NRG is synthesized notsystem. Evidence was presented indicating that NRG
only by motor neurons but also by skeletal muscle cellsmay have a clinically beneficial role as a therapeutic
(Moscoso et al., 1995; Rimer et al., 1996, Soc. Neurosci.agent for multiple sclerosis. C. Raine (Albert Einstein
abstract), and the persistence of the membrane-boundCollege of Medicine, New York) used an adoptive trans-
form of NRG at denervated synapses demonstrates thatfer model of experimental allergic encephalomyelitis
muscle cells contribute NRG to the synaptic site (Rimer(EAE) to determine whether NRG might reduce the rate
et al., 1996, Soc. Neurosci. abstract). Because the Ig iso-or extent of demyelination. In this model, clinical re-
form is the major NRG isoform in skeletal muscle cellslapses areepisodic, and they are associated with inflam-
(X. Yang and Burden), the phenotype of the NRGIg1/2mation, demyelination, and remyelination. Raine re-
ported that repeated injections of NRG at different times mice may be explained by a reduction in muscle-derived
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rather than in motor neuron-derived NRG. Moreover, NRG Actions on Neurons and Cranial Nerves
Because NRGs and their direct receptors are widelysince muscle cells synthesize NRGand ErbBs, and local-
ize both ligands and receptors to the synaptic site, NRG- expressed by neurons of the central and peripheral ner-
vous systems, paracrine and autocrine regulation ofErbB signaling at the synapse may function, at least
in part, by an autocrine mechanism (Burden), involving nerves by NRG is possible. Disruption of all NRG iso-
forms, or only Ig-containing isoforms, resulted,however,activation of a Ras/ERK2-dependent pathway (Altiok et
al., 1997). in neural defects that were limited to cranial nerves at
the time of death of mutant animals. Specifically, theAgrin is an important signal for neuromuscular syn-
apse formation, since mice lacking agrin or MuSK, a neural crest±derived component of cranial ganglia V (tri-
geminal), and to a lesser extent that of ganglia VII±IX,component of its receptor complex, lack neuromuscular
synapses. Because mice lacking agrin (Gautam et al., were severely reduced in size. In addition, these ganglia
were disconnected, either completely or partially, from1996) or MuSK (DeChiara et al., 1996) fail to cluster
ErbBs, NRG-ErbB signaling is likely to depend on agrin/ the hindbrain. Apparently, NRG controls survival, rather
than migration, of cells originating in the NRG-express-MuSK signaling. Agrin is sufficient to cluster NRG and
ErbBs in skeletal muscle, since forced ectopic expres- ing hindbrain rhombomeres 2, 4, and 6 (Meyer and Birch-
meier, 1995). These neural crest±derived cells are al-sion of neural agrin at nonsynaptic sites in skeletal mus-
cle cells caused not only AChRs but also ErbBs and ready committed to a neural fate, and their survival
specifically depends on an Ig-containing NRG (C. Birch-pro-NRG to cluster at the ectopic site (Rimer et al., 1996,
Soc. Neurosci. abstract). Thus, agrin/MuSK signaling meier). Survival is mediated by ErbB-2 and ErbB-3, but
not an active ErbB-4, as ErbB-22/2 and ErbB-32/2miceregulates the distribution of muscle-derived NRG and
ErbBs. shared a similar cranial nerve phenotype with NRG2/2
mice (Lee; Erickson), but both ganglia size and hindbrainIdentification of an ErbB-binding protein, which, like
the ErbBs, is concentrated at neuromuscular synapses, connections were not affected in ErbB-42/2 mice (M.
Gassman, Salk Institute). Instead, in the latter animals,was described by K. Carraway (Harvard). This heregulin
receptor binding (HRB) protein, identified in a yeast two- ganglia V, VII, and VIII are almost fused, and their con-
nections are mistargeted: the trigeminal and facial gan-hybrid screen using the cytoplasmic domain of ErbB-3
as bait, is expressed in heart, skeletal muscle, and brain. glia are each connected to both rhombomeres 2 and 4,
instead of their normal single links to rhombomeres 2The protein is myristolated, has an imperfect ring finger
domain, and can bind both ErbB-3 and ErbB-4 in vitro, and 4, respectively. The reason for mistargeting is cur-
rently unknown, but it probably relates to the localizedalthough the binding does not appear to depend on
ErbB phosphorylation. Like rapsyn-induced clustering expression of ErbB-4 in the intervening odd numbered
rhombomeres 3 and 5 (Lemke, 1996). Alternatively, mis-of AChRs in nonmuscle cells, HRB appears to regulate
the clustering of ErbB-3 in transfected COS cells. targeting isnot seen inNRG2/2 embryos as a result of the
extensive cell loss in their cranial ganglia (Gassmann).The role of NRG in regulating the nonmyelinating ter-
minal Schwann cells at the neuromuscular synapse was Another possible explanation for the discordant NRG
and ErbB-4 phenotypes is the existence of additionaladdressed by W.Thompson. In mammalian muscle,syn-
aptic sites are usually organized in an endplate band ErbB-4 ligands, such as betacellulin (Riese et al., 1996),
HB-EGF, or NRG2. Alternatively, reciprocal mechanismsadjacent to themain intramuscular nerve. Schwann cells
within skeletal muscle are restricted to these intramus- involving other neurotrophic factors may be involved.
For example, sympathetic neuroblast-derived NRG cancular nerves and to synaptic sites. Injection of NRG into
skeletal muscle of neonatal mice, however, resulted in induce synthesis of nerotrophin-3 (NT-3) by nonneuronal
cells, thereby affecting in an indirect way the survivalthe proliferation and redistribution of Schwann cells
throughout the muscle. Motor axons in NRG-injected of neurons (Verdi et al., 1996). Potentially, this or a similar
mechanism may underlie the observation that NRG pro-muscle are likewise found throughout the muscle. Since
prior studies by Thompson indicated that Schwann cells motes survival and neurite outgrowth of cultured embry-
onic retinal cells (O. Bermingham-McDonogh, Universityare likely to have an important role in guiding motor
axons to denervated synaptic sites (Son and Thompson, of Washington, Seattle).Neurons isolated from neonates
(P4) lost responsiveness to NRG, in parallel to a de-1995), these new results raise the possibility that NRG,
possibly provided by skeletal muscle, indirectly regu- creased expression of ErbB-2 (Bermingham-McDonogh
et al., 1996). Thus, neurite outgrowth in retinal cells, aslates the position of motor axons by regulating the num-
ber and position of Schwann cells in muscle. well as in the more extensively studied PC-12 cell line
(Gamett et al., 1995), correlates with ErbB-2 expression,Although NRG2, like NRG1, binds to ErbB-3 and to
ErbB-4 and concomitantly stimulates their association reemphasizing a receptor-coded specificity biological
effect of NRGs.with other ErbB family members, resulting in ligand-
stimulated tyrosine phosphorylation, NRG1, but not Reciprocal interactions involving NRG also play a role
in neural migration. E. Anton (Yale) and G. Corfas (Har-NRG2, activates expression of AChR genes in muscle
cell lines (Lai, Yang, and Burden; A. Goodearl, Millenium vard; Rio et al., 1997) studied migration in the cerebral
cortex and in the cerebellum, respectively, and con-Pharmaceuticals). Similarly, NRG1 but not NRG2 stimu-
lates Schwann cell proliferation. These unexpected re- cluded that neuron-derived NRG instructs the underly-
ing glia, either radial glia or the cerebellar Bergmannsults raise the possibility that the extent or duration of
signaling by NRG1 and NRG2 may differ and account glia, to promote directed neuron movement. In the cortex,
glia-expressed ErbB-2 is involved, perhaps in collabora-for the different biological responses observed in mus-
cle and in Schwann cells. tion with ErbB-3 and ErbB-4; in Bergmann glia, NRG
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induced CREB phosphorylation. Migration could be during puberty, and also promoted mammary tumors
(Krane and Leder, 1996). Thus, NRGs appear to induceblocked either by an anti-NRG antibody added to ex-
plants of the cerebral cortex or by a dominant-negative growth and inhibit differentiation of the primitive epithe-
lial duct, but later in development these factors enhancemutant of ErbB-4 ectopically expressed in glia cells. In
both the developing cerebral cortex and cerebellum, mammary differentiation.
The reason that epithelial defects are not prominentlyNRG promoted the neuron-primed elongation of glial
cells, but not their adhesion to neuronal cells, indicating detectable in NRG-, ErbB-2-, and ErbB-4-targeted mice
is probably due to the early embryonic death of thethat NRG directly induces radial morphology of the glia,
and this cell reciprocally promotes neuron migration mutant mice, and the relatively late onset of epithelial
organogenesis. Indeed, major defects in epithelia ofthrough an unknown mechanism.
Acoustic trauma (exposure to excessive noise for a skin, lung, hair, placenta, and other organs were de-
tected in ErbB-1-defective mice (which live longer thanlong time, or to certain antibiotics and diuretics) may
lead to loss of mechanosensory hair cells from the co- NRG2/2 mice). Likewise, ErbB-3-defective mice (which
live 3 days longer than NRG2/2 mice) already displaychlea, resulting in irreversible deficits in hearing. In cer-
tain species, these damaged epithelial cells can be re- some abnormalities in stomach and in pancreas (Erick-
son). Another reflection of the role of ErbB-3 in epithelialplaced by division of supporting cells, which share some
features with Schwann cells. Jeff Corwin (University of differentiation was derived from an in vivo model of
wound healing, where NRG was found to mediate bothVirginia, Charlottesville) reported that postnatal rat sup-
porting cells undergo mitosis in response to NRG, and epidermal migration and up-regulation of keratinocyte
differentiation markers (Danilenko et al., 1995). As ex-to a lesser extent to one of the ErbB-1 ligands (TGFa),
suggesting yet another clinical application of these pected from other inductive actions of NRG, the ligand
is secreted by skin fibroblasts and affects nearby kera-growth factors.
tinocytes, whose expression of ErbB proteins changes
during reepithelialization.
NRGs in Epithelial Morphogenesis The dynamic pattern of ErbB expression during cell
The wealth of informationon NRGs as primary mediators fate determination and morphogenic processes appar-
of nerve communication with neighboring nonneuronal ently dictates the nature of cellular response. This ap-
cells may be paralleled by initial reports of similar inter- pears to be true in all in vitro models of NRG actions,
actions in other epithelial organs, whose cellular hetero- including Schwann cells. As oligodendrocytes differenti-
geneity and complex anatomical connections are reminis- ate, ErbB-4 is down-regulated, and ErbB-2 expression
cent of the nervous system. Morphogenesis of epithelial is increased (Canoll et al., 1996), whereas during skeletal
organs is controlled, in part, by multiple polypeptide muscle differentiation, ErbB-3 expression is strongly in-
factors secreted by the underlying stromal mesen- duced while ErbB-2 expression remains unchanged (Jo
chyme. With the exception of ErbB-4, whose expression et al., 1995). Dramatic examples of how the repertoire
is limited to certain epithelia, the three other receptors of ErbB proteins might affect cell function are provided
and coreceptors of NRGs are present in most epithelial by several types of epithelial cancers (carcinomas):
cell layers. Moreover, mesenchymal cells are the richest some tumors overexpress ErbB-2 at levels 100-fold
source, outside of the nervous system, of the corre- greater than normal, and in some types of cancers, the
sponding ligands, both NRGs and ErbB-1-specific li- extent of overexpression predicts disease outcome and
gands. An example of NRG action in mesenchyme± response to hormone- and chemotherapy. Apparently,
epithelial interactions isprovided by themammary gland ErbB-2 overexpression in epithelial cells biases forma-
(C., and W. Birchmeier, Max DelbruÈ ck Center, Berlin). tion of its more potent heterodimers, leading to en-
The gland is one of a few organs in which major morpho- hanced proliferation at the expense of a differentiated
genesis takes place after birth. During puberty, it in- phenotype. On the other hand, blocking ErbB-2 action
volves branching and elongation that result in a ductal by using anti-ErbB-2 monoclonal antibodies results in
tree. A second budding phase, during pregnancy, gener- retardation of cell proliferation, an effect that has been
ates the milk-producing lobuloalveolar structures. Anal- recently used in breast cancer patients to inhibit mam-
yses of organ cultures of the mouse mammary gland mary tumor growth (Baselga et al., 1996).
suggest that NRG, whose expression peaks at preg-
nancy, regulates the second morphogenic phase by Conclusions
stimulating lobuloalveolar budding and milk production. Results obtained in the few years since the NRG family
Of note, synthesis of milk components (e.g., casein and was discovered already make it clear that this signaling
neutral lipids) in response to NRG is retained in vitro by module is involved in a myriad of physiological and de-
certain mammary cell lines. velopmental processes, as well as in pathological
Interestingly, when pellets releasing NRG were im- states. This multiplicity of biological functions likely re-
planted within the mammary glands of prepubescent flects the enormous biochemical potential of the NRG-
female mice, NRG-a, but not NRG-b, could induce ductal ErbB network to diversify signals. The available NRG2
branching and migration in the absence of exogenous isoforms, together with the possible existence of addi-
steroid hormones, but both isoforms were active in in- tional ErbB receptors and a direct ErbB-2 ligand, may
duction of secretory lobuloalveoli (Jones et al., 1996). extend the ensuing complexity even further. Results
Mice engineered to constitutively overexpress NRG-b2 from mice with targeted mutations support the possibil-
in the mammary gland displayed persistence of the ity that this signaling complexity, which has been estab-
lished by expression studies and in vitro experiments, ismammary end bud structures, which normally disappear
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